The April 2024 issue of Topics in Antiviral Medicine™ is Now Available
The April 2024 issue of Topics in Antiviral Medicine™ (TAM) is now available at https://www.iasusa.org/tam/april-2024/. This issue offers up to 3.75 CME credits and includes 3 invited reviews on the topics of long COVID; mRNA vaccine technology for SARS-CoV-2 and prospects for an HIV-1 vaccine; and routine and special vaccinations in people with HIV. This issue also features a case report on the challenge of adherence to a complex antiretroviral therapy regimen in an individual with multidrug-resistant HIV.
Invited Reviews
Long-Term Effects of COVID-19: The Stories of 2 Physicians Who Became Patients
James Mwangi, MD, Jeffrey N. Siegelman, MD
https://www.iasusa.org/wp-content/uploads/2024/02/32-2-mwangi-siegelman.pdf
Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine
Jacob K. Files, MD, PhD, Paul A. Goepfert, MD
https://www.iasusa.org/wp-content/uploads/2024/02/32-2-files-goepfert.pdf
Routine and Special Vaccinations in People With HIV
Hillary A. Dunlevy, MD, MPH;, Steven C. Johnson, MD
https://www.iasusa.org/wp-content/uploads/2024/02/32-2-dunlevy-johnson.pdf
Case Report
Marco Moretti, MD, Karolien Stoffels, PhD, Kristel Van Laethem, PhD, Chris Verhofstede, PhD, Sigi Van Den Wijngaert, MD, Charlotte Martin, MD, PhD
https://www.iasusa.org/wp-content/uploads/2024/02/32-2-moretti-martin.pdf
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The IAS–USA designates this issue for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.